Spinal Cord Volume Loss in Primary Progressive MS Correlates With Disability
Spinal cord volume loss may be a predictor of clinical outcomes in primary progressive multiple sclerosis.
All articles by Sunali Wadehra, MD
Erenumab May Help Prevent Migraines in Patients With Heart Disease
Investigators assessed the effect of erenumab on total exercise time, time to exercise-induced angina, and ST depression in patients with stable angina.
Cladribine May Be Beneficial for Managing Progressive Multiple Sclerosis
Patients with increased disease activity seen on MRI or with elevated CSF NfL should be considered for disease-modifying immune therapy.
Overuse of Neuroimaging in the Emergency Department Reported for Pediatric Headache
Investigators examined rates, predictors, and outcomes of neuroimaging in pediatric and adolescent patients who presented to the ED with a headache.
Hemiplegic Migraine Aura Alleviated by OnabotulinumtoxinA Injections
Investigators examined the effect of onabotulinumtoxinA on aura frequency and severity in patients with hemiplegic migraine.
Oral Steroids Perform Better Than Injection in Short-Term Cluster Headache Management
Investigators examined the efficacy of oral steroids and greater occipital nerve injections as transitional therapies for cluster headache management.
Cognitive Performance, Mood Deficits, White Matter Hyperintensities in Migraine
Carefully assessing cognitive performance using a screening test to detect visuospatial/executive, attention, and memory dysfunction in patients with migraine.
Sleep Quality in Chronic Tension-Type Headaches
Investigators examined baseline and 1-year variables and their association with quality of sleep in chronic tension-type headaches.
Managing Pediatric Migraine: Current Therapies and Future Directions
Migraine is highly prevalent in children and adolescents, affecting almost 10% of children between 5 and 15 years old and 30% of adolescents between 15 and 19 years old.
Online Fatigue Management Feasible, Effective for Multiple Sclerosis
Investigators designed a parallel-group, 2-arm, randomized controlled trial to evaluate ELEVIDA, an online fatigue management program based on cognitive behavioral therapy and other therapy-based strategies.
Next post in Multiple Sclerosis
